These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 12738750)

  • 41. Thymidine kinase and thymidine phosphorylase level as the main predictive parameter for sensitivity to TAS-102 in a mouse model.
    Emura T; Nakagawa F; Fujioka A; Ohshimo H; Kitazato K
    Oncol Rep; 2004 Feb; 11(2):381-7. PubMed ID: 14719072
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Albumin-based drug carriers: comparison between serum albumins of different species on pharmacokinetics and tumor uptake of the conjugate.
    Stehle G; Wunder A; Schrenk HH; Hartung G; Heene DL; Sinn H
    Anticancer Drugs; 1999 Sep; 10(8):785-90. PubMed ID: 10573211
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of methotrexate on thymidylate synthetase in cultured parenchymal cells isolated from regenerating rat liver.
    Bonney RJ; Maley F
    Cancer Res; 1975 Aug; 35(8):1950-6. PubMed ID: 1170938
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CHS 828, a novel pyridyl cyanoguanidine with potent antitumor activity in vitro and in vivo.
    Hjarnaa PJ; Jonsson E; Latini S; Dhar S; Larsson R; Bramm E; Skov T; Binderup L
    Cancer Res; 1999 Nov; 59(22):5751-7. PubMed ID: 10582695
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects and interaction of 7-hydroxy methotrexate and methotrexate in leukaemic cells ex vivo measured by the thymidylate synthase inhibition assay.
    Lingg RM; Hempel G; Rots MG; Van Zantwijk CH; Boos J; Kaspers GJ
    Cancer Chemother Pharmacol; 2005 Sep; 56(3):322-7. PubMed ID: 15868145
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Earthworm fibrinolytic enzyme: anti-tumor activity on human hepatoma cells in vitro and in vivo.
    Chen H; Takahashi S; Imamura M; Okutani E; Zhang ZG; Chayama K; Chen BA
    Chin Med J (Engl); 2007 May; 120(10):898-904. PubMed ID: 17543180
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibody-directed enzyme prodrug therapy with the T268G mutant of human carboxypeptidase A1: in vitro and in vivo studies with prodrugs of methotrexate and the thymidylate synthase inhibitors GW1031 and GW1843.
    Wolfe LA; Mullin RJ; Laethem R; Blumenkopf TA; Cory M; Miller JF; Keith BR; Humphreys J; Smith GK
    Bioconjug Chem; 1999; 10(1):38-48. PubMed ID: 9893962
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis.
    Pourgholami MH; Akhter J; Wang L; Lu Y; Morris DL
    Cancer Chemother Pharmacol; 2005 May; 55(5):425-32. PubMed ID: 15565325
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The hollow fiber assay: continued characterization with novel approaches.
    Hall LA; Krauthauser CM; Wexler RS; Hollingshead MG; Slee AM; Kerr JS
    Anticancer Res; 2000; 20(2A):903-11. PubMed ID: 10810375
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aminopeptidase inhibitor ubenimex (bestatin) inhibits the growth of human choriocarcinoma in nude mice through its direct cytostatic activity.
    Inoi K; Goto S; Nomura S; Isobe K; Nawa A; Okamoto T; Tomoda Y
    Anticancer Res; 1995; 15(5B):2081-7. PubMed ID: 8572606
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Telomerase antisense inhibition and chemotherapeutic combination treatments for the proliferation of endometrial cancer in vitro and in vivo].
    Chen XJ; Zheng W; Chen LL; Chen ZB; Wang SQ
    Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(20):1721-5. PubMed ID: 15569435
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sequence-dependent antitumor effects of differentiation agents in combination with cell cycle-dependent cytotoxic drugs.
    Verheul HM; Qian DZ; Carducci MA; Pili R
    Cancer Chemother Pharmacol; 2007 Aug; 60(3):329-39. PubMed ID: 17256134
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Methotrexate-albumin and aminopterin-albumin effectively prevent experimental acute graft-versus-host disease.
    Wolff D; Frei E; Hofmeister N; Steiner B; Kleine HD; Junghanss C; Sievert K; Terpe H; Schrenk HH; Freund M; Hartung G
    Transplantation; 2006 Aug; 82(4):527-33. PubMed ID: 16926597
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of methotrexate-monoclonal anti-prostatic acid phosphatase antibody conjugate on human prostate tumor.
    Deguchi T; Chu TM; Leong SS; Horoszewicz JS; Lee CL
    Cancer Res; 1986 Aug; 46(8):3751-5. PubMed ID: 3731053
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro and in vivo prodrug therapy of prostate cancer using anti-gamma-Sm-scFv/hCPA fusion protein.
    Hao XK; Liu JY; Yue QH; Wu GJ; Bai YJ; Yin Y
    Prostate; 2006 Jun; 66(8):858-66. PubMed ID: 16491483
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of lovastatin alone or combined with irradiation on tumor cells in vitro and in vivo.
    Gabryś D; Dörfler A; Yaromina A; Hessel F; Krause M; Oertel R; Baumann M
    Strahlenther Onkol; 2008 Jan; 184(1):48-53. PubMed ID: 18188523
    [TBL] [Abstract][Full Text] [Related]  

  • 57. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
    Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
    Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Osteosarcoma cells, resistant to methotrexate due to nucleoside and nucleobase salvage, are sensitive to nucleoside analogs.
    Cole PD; Smith AK; Kamen BA
    Cancer Chemother Pharmacol; 2002 Aug; 50(2):111-6. PubMed ID: 12172974
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thymidylate synthetase and thymidine kinase activities and methotrexate cytotoxicity during growth of L1210 and Ehrlich ascites tumor.
    Hullán L; Szikla K; Tusnády G; Holczinger L
    Cancer Biochem Biophys; 1988 Nov; 10(2):131-9. PubMed ID: 3252959
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effects of CPUY013, a novel Topo I inhibitor, on human gastric adenocarcinoma BGC823 cells in vitro and in vivo].
    Ji YB; Zhou JH; Zuo MX; You QD
    Yao Xue Xue Bao; 2008 Aug; 43(8):811-8. PubMed ID: 18956773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.